How much revenue does Colinz Laboratories make?

Colinz Laboratories reported 65.28 million INR in revenue for fiscal year 2025, down 7.1% from 70.30 million INR in fiscal year 2024. In Q3 2026 revenue was 14.34 million INR.

What companies are similar to Colinz Laboratories?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Welcure Drugs and Pharmaceuticals Limited (WELCURE.BO), Venmax Drugs AND Pharmaceutica (VENMAX.BO), Chemo Pharma Laboratories Limited (CHEMOPH.BO), Hemo Organic Limited (HEMORGANIC.BO).

Colinz Laboratories Limited (COLINZ.BO) Stock

About Colinz Laboratories Limited

Colinz Laboratories Limited manufactures and trades in pharmaceutical formulations in India. The company offers pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, ointments, injectables, creams, syrups, suppositories, etc.; and specialized products for gynaecology, cardiology, and gastroenterology, etc. Its allopathy products include oncology products, su...

At a glance

Colinz Laboratories reported revenue of 65.28 million INR for fiscal year 2025, down 7.1% from fiscal year 2024, and net income of 4.97 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 14.34 million INR, down 2.2% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.